Deciphering the role of miR-22 in metabolic reprogramming and tumor suppression of hepatocellular carcinoma

被引：0

作者：

Valenti, F. ^{[1
]}

Leoni, I. ^{[2
,3
]}

Galvani, G. ^{[2
,3
]}

Monti, E. ^{[2
,3
]}

Pincigher, L. ^{[1
]}

Rizzardi, N. ^{[1
]}

Vianello, C. ^{[2
,3
]}

Negrini, M. ^{[4
]}

Domenicali, M. ^{[5
]}

Vasuri, F. ^{[6
]}

Stefanelli, C. ^{[3
]}

Gramantieri, L. ^{[7
]}

Marinelli, S. ^{[7
]}

Piscaglia, F. ^{[7
]}

Giovannini, C. ^{[2
]}

Baldassarre, M. ^{[6
]}

Ravaioli, M. ^{[8
]}

Cescon, M. ^{[8
]}

Fornari, F. ^{[2
,3
]}

Bergamini, C. ^{[1
]}

Fato, R. ^{[1
]}

机构：

[1] Univ Bologna, Dept Pharm & Biotechnol, I-40126 Bologna, Italy

[2] Univ Bologna, Ctr Appl Biomed Res CRBA, Policlin St Orsola, I-40138 Bologna, Italy

[3] Univ Bologna, Dept Life Qual Studies, I-47921 Rimini, Italy

[4] Univ Ferrara, Dept Morphol Surg & Expt Med, I-44100 Ferrara, Italy

[5] Univ Bologna, Dept Med & Surg Sci, I-40138 Bologna, Italy

[6] IRCCS Azienda Osped Univ Bologna, Dept Pathol, I-40138 Bologna, Italy

[7] IRCCS Azienda Osped Univ Bologna, Div Internal Med Hepatobiliary & Immunoallerg Dis, I-40138 Bologna, Italy

[8] IRCCS Azienda Osped Univ Bologna, Dept Gen Surg & Transplantat, I-40138 Bologna, Italy

来源：

FEBS OPEN BIO | 2024年 / 14卷

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

P-26-057

引用

页码：274 / 274

页数：1

共 50 条

[21] MiR-22 decreases the migration of nasopharyngeal carcinoma by TRPM7
Zhu, Zi-Yu
Duan, Bing-Yue
You, Bo
Yue, Hui-Jun
Shi, Si
Shan, Ying
Bao, Li-Li
Sheng, Ju-Ping
You, Yi-Wen
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (07): : 6808 - 6815
[22] miR-22 targets YWHAZ to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival
Chen, Ming
Hu, Wei
Xiong, Chen-Ling
Qu, Zhen
Yin, Chang-Qing
Wang, Yu-Hui
Luo, Chang-Liang
Guan, Qing
Yuan, Chun-Hui
Wang, Fu-Bing
ONCOTARGET, 2016, 7 (49) : 80751 - 80764
[23] A role for miR-22 and miR-26a in muscle glucose uptake and insulin sensitivity
Andersen, D. K.
Cobb, B.
Cleasby, M. E.
DIABETIC MEDICINE, 2015, 32 : 46 - 47
[24] EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis
Chen, Shaofei
Pu, Jiarui
Bai, Jie
Yin, Yuping
Wu, Ke
Wang, Jiliang
Shuai, Xiaoming
Gao, Jinbo
Tao, Kaixiong
Wang, Guobin
Li, Hang
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2018, 37
[25] miR-22 and miR-205 Drive Tumor Aggressiveness of Mucoepidermoid Carcinomas of Salivary Glands
Naakka, Erika
Barros-Filho, Mateus Camargo
Adnan-Awad, Shady
Al-Samadi, Ahmed
Marchi, Fabio Albuquerque
Kuasne, Hellen
Korelin, Katja
Suleymanova, Ilida
Brown, Amy Louise
Scapulatempo-Neto, Cristovam
Lourenco, Silvia Vanessa
Castilho, Rogerio Moraes
Kowalski, Luiz Paulo
Maekitie, Antti
Araujo, Vera Cavalcanti
Leivo, Ilmo
Rogatto, Silvia Regina
Salo, Tuula
Passador-Santos, Fabricio
FRONTIERS IN ONCOLOGY, 2022, 11
[26] EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis
Shaofei Chen
Jiarui Pu
Jie Bai
Yuping Yin
Ke Wu
Jiliang Wang
Xiaoming Shuai
Jinbo Gao
Kaixiong Tao
Guobin Wang
Hang Li
Journal of Experimental & Clinical Cancer Research, 37
[27] Metabolic reprogramming in hepatocellular carcinoma: mechanisms and therapeutic implications
Park, Sujin
Hall, Michael N.
EXPERIMENTAL AND MOLECULAR MEDICINE, 2025, 57 (03): : 515 - 523
[28] Research progress in the metabolic reprogramming of hepatocellular carcinoma (Review)
Gao, Wenyue
Wang, Jing
Xu, Yuting
Yu, Hongbo
Yi, Sitong
Bai, Changchuan
Cong, Qingwei
Zhu, Ying
MOLECULAR MEDICINE REPORTS, 2024, 30 (01)
[29] Metabolic Reprogramming and Its Relationship to Survival in Hepatocellular Carcinoma
Wang, Qingqing
Tan, Yexiong
Jiang, Tianyi
Wang, Xiaolin
Li, Qi
Li, Yanli
Dong, Liwei
Liu, Xinyu
Xu, Guowang
CELLS, 2022, 11 (07)
[30] An Immunocompetent Environment Unravels the Proto-Oncogenic Role of miR-22
Centomo, Maria Laura
Vitiello, Marianna
Poliseno, Laura
Pandolfi, Pier Paolo
CANCERS, 2022, 14 (24)

← 1 2 3 4 5 →